Feedback / Questions
eblasakimab (ASLAN004) - ASLAN Pharma
https://www.prnewswire.com/news-releases/aslan-pharmaceuticals-signs-license-agreement-with-belleai-to-use-bellestudy-image-capture-software-in-atopic-dermatitis-clinical-trials-301612044.html
Aug 25, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next